People: WebMD Health Corp (WBMD.O)
WBMD.O on Nasdaq
27.41USD
19 Jun 2013
27.41USD
19 Jun 2013
Price Change (% chg)
$-0.68 (-2.42%)
$-0.68 (-2.42%)
Prev Close
$28.09
$28.09
Open
$28.01
$28.01
Day's High
$28.30
$28.30
Day's Low
$27.34
$27.34
Volume
403,502
403,502
Avg. Vol
359,570
359,570
52-wk High
$31.63
$31.63
52-wk Low
$13.13
$13.13
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Martin Wygod |
72 | 2005 | Executive Chairman of the Board |
David Schlanger |
53 | 2013 | Interim Chief Executive Officer |
Peter Anevski |
45 | 2013 | Chief Financial Officer, Executive Vice President |
William Pence |
49 | 2012 | Chief Operating Officer, Executive Vice President, Chief Technology Officer |
Douglas Wamsley |
53 | 2005 | Executive Vice President, General Counsel, Secretary |
David Marek |
2012 | Executive Vice President - Consumer Services | |
Steven Zatz |
55 | 2005 | Executive Vice President - Professional Services |
Kevin Cameron |
45 | 2009 | Director |
Thomas Coleman |
46 | 2012 | Director |
David Schechter |
2012 | Director | |
Mark Adler |
55 | 2005 | Independent Director |
Neil Dimick |
63 | 2005 | Independent Director |
Jerome Keller |
69 | 2005 | Independent Director |
James Manning |
65 | 2005 | Independent Director |
Abdool Moossa |
72 | 2005 | Independent Director |
Herman Sarkowsky |
86 | 2009 | Independent Director |
Joseph Smith |
73 | 2009 | Independent Director |
Stanley Trotman |
68 | 2005 | Independent Director |
Risa Fisher |
Investor Relations Officer |
Biographies
| Name | Description |
|---|---|
Martin Wygod |
Mr. Martin J. Wygod is Executive Chairman of the Board of WebMD Health Corporation since May 2005. From March 2001 until the Merger in October 2009, Mr. Wygod served as HLTH’s Chairman of the Board and served as a member of its Board of Directors from September 2000 until the Merger. Mr. Wygod also served as HLTH’s Acting Chief Executive Officer from February 2008 until the Merger and as its Chief Executive Officer from September 2000 until May 2003. He is also engaged in the business of racing, boarding and breeding thoroughbred horses, and is President of River Edge Farm, Inc. Mr. Wygod’s qualifications for membership on WebMD’s Board of Directors include: his prior service as an executive officer and director of WebMD, HLTH and predecessor companies and as an executive officer and director of other companies in the healthcare industry. |
David Schlanger |
Mr. David J. Schlanger has been appointed as Interim Chief Executive Officer of WebMD Health Corp., effective May 7, 2013. Mr. Schlanger has been with WebMD and its predecessor companies for 18 years, most recently as Senior Vice President, Strategic and Corporate Development. In this role, he was responsible for providing strategic support throughout the organization, including sales, marketing, client relationship management, and product development. Mr. Schlanger and his team have led all aspects of the structuring, negotiating and management of key strategic partnerships with some of WebMD's clients as well as its media, technology and content partners. Additionally, he was the lead executive responsible for the strategy, sourcing, negotiation and diligence on the numerous acquisitions that form the core of WebMD's current business. He has also been responsible for international initiatives, including WebMD's joint venture with Boots in the United Kingdom, which since its creation has grown to be the commercial online health destination in the UK. |
Peter Anevski |
Mr. Peter Anevski has been appointed as Chief Financial Officer, Executive Vice President of WebMD Health Corp., effective May 7, 2013. Mr. Anevski has served in senior finance and operations roles during the past 14 years at WebMD and its predecessor companies. He was most recently Senior Vice President, Finance, responsible for all aspects of internal accounting, SEC reporting and compliance, financial planning, merger and acquisition analysis and integration. Mr. Anevski played an integral role in WebMD's recent restructuring as well as developing the changes initiated in early 2012 related to WebMD's pricing structure and market positioning, both of which are driving improved financial results. |
William Pence |
Dr. William Pence is Chief Operating Officer, Executive Vice President, Chief Technology Officer of WebMD Health Corporation. He has been appointed as Chief Operating Officer of the company effective May 16, 2012. Before joining WebMD, Mr. Pence had served as Chief Technology Officer and Senior Vice President at Napster since 2003. From 2000 to 2003, Mr. Pence was the Chief Technology Officer for Universal Music Group’s online initiatives and for the pressplay joint venture with Sony. That joint venture later served as the basis for the relaunched Napster service. Previously, Mr. Pence spent more than a decade at IBM, where he held various technology management positions in research as well as in the software division, focused on guiding research and development and commercializing technology for IBM product divisions. Mr. Pence received a Bachelor of Science in Physics from the University of Virginia, and a Ph.D. in Electrical Engineering from Cornell University. |
Douglas Wamsley |
Mr. Douglas W. Wamsley is Executive Vice President, General Counsel, Secretary of WebMD Health Corporation since July 2005. From September 2001 until July 2005, Mr. Wamsley served as Senior Vice President — Legal of HLTH, focusing on its WebMD segment. |
David Marek |
Mr. David C. Marek is an Executive Vice President - Consumer Services of WebMD Health Corp., since September 4, 2012. He brings to WebMD 20 years of healthcare industry and agency experience. David has spent a decade within Publicis Groupe where he led the flagship healthcare agency at Saatchi & Saatchi Health, New York, prior to being named Worldwide Business Director for Publicis. He has a record of performance as a business leader and is recognized for his ability to capitalize on emerging opportunities that translate into success for the organization and its healthcare clients. Prior to his agency years, he spent ten years in pharmaceutical sales and marketing, launching and building brands at Eli Lilly and AstraZeneca. He was with the business intelligence think-tank Inferential Focus. |
Steven Zatz |
Dr. Steven Zatz, M.D., is Executive Vice President - Professional Services of WebMD Health Corporation since July 2005. From October 2000 to July 2005, Dr. Zatz had similar responsibilities at HLTH, where he focused on the physician portals. Dr. Zatz was Senior Vice President, Medical Director of CareInsite, Inc. from June 1999 until its acquisition by HLTH in September 2000. Prior to joining CareInsite, Dr. Zatz was a Senior Vice President of RR Donnelly Financial in charge of its healthcare business from October 1998 to May 1999. From August 1995 to May 1998, Dr. Zatz was President of Physicians’ Online, an online portal for physicians. |
Kevin Cameron |
Mr. Kevin M. Cameron is Director of WebMD Health Corporation since October 2009, upon completion of the Merger. Mr. Cameron had been a member of HLTH’s Board of Directors from October 2004 until the Merger. He also served as Chief Executive Officer of HLTH from October 2004 until February 2008, when he went on medical leave. Since November 2009, Mr. Cameron has served as Special Advisor to the Chairman of WebMD. From November 2005 until November 2006, Mr. Cameron also served as Acting CEO of Emdeon Business Services, which was then one of HLTH’s segments. From January 2002 until October 2004, Mr. Cameron was Special Advisor to the Chairman of HLTH. From September 2000 to January 2002, he served as Executive Vice President, Business Development of HLTH and, in addition, from September 2001 through January 2002, was a member of the Office of the President. From April 2000 until its merger with HLTH in September 2000, Mr. Cameron served as Executive Vice President, Business Development of a predecessor to HLTH. Prior to April 2000, Mr. Cameron was a Managing Director of the Health Care Investment Banking Group of UBS and held various positions at Salomon Smith Barney. Mr. Cameron’s qualifications for membership on WebMD’s Board of Directors include: his prior service as an executive of WebMD and predecessor companies (including his service as Chief Executive Officer of HLTH) and on HLTH’s Board; and his experience as an investment banker specializing in healthcare, as described above. |
Thomas Coleman |
Mr. Thomas Jason Coleman has been appointed as Director of WebMD Health Corp. effective October 17, 2012. Mr. Coleman has served as co-Founder and co-President of Kensico Capital Management Corporation (“Kensico”), an investment management services company, since January 2000. Mr. Coleman is also the co-principal of Kensico’s affiliates. Prior to working with Kensico and its affiliates, Mr. Coleman was employed by Halo Capital Partners, the investment adviser to Tyndall Partners, L.P., an investment adviser, as an analyst and then a partner. Prior to his employment at Halo, Mr. Coleman founded and served as Chief Executive Officer and a director of PTI Holding Inc., a manufacturer of bicycle helmets, bicycle accessories, athletic footwear and personal products, from 1990 until 1995. From February 2011 until its sale in January 2012, Mr. Coleman served as a director of Tekelec, a publicly traded global provider of core network solutions. |
David Schechter |
Mr. David Schechter is appointed as the Director of WebMD Health Corp. |
Mark Adler |
Dr. Mark J. Adler, M.D., is Independent Director of WebMD Health Corporation since September 2005. From September 2000 until completion of WebMD’s merger with HLTH Corporation (which refer to as HLTH), the former parent company of WebMD, in October 2009 (the Merger), Dr. Adler was a member of HLTH’s Board of Directors. Dr. Adler is an oncologist and served for over ten years as Chief Executive Officer of the San Diego Cancer Center until its acquisition in February 2011 by the University of California. He continues as a director of this cancer center and is a director of the San Diego Cancer Research Institute. Until April 2006, he had also served, for more than five years, as the Chief Executive Officer of the combined internal medicine and oncology group of Medical Group of North County in San Diego, California. Dr. Adler’s qualifications for membership on WebMD’s Board of Directors include: his many years of experience as a physician and an executive of a physician practice; and his prior service as a director of WebMD, HLTH and predecessor companies. |
Neil Dimick |
Mr. Neil F. Dimick, CPA, is Independent Director of WebMD Health Corporation since September 2005. From December 2002 until completion of the Merger in October 2009, Mr. Dimick was a member of HLTH’s Board of Directors. Mr. Dimick served as Executive Vice President and Chief Financial Officer of AmerisourceBergen Corporation, a wholesale distributor of pharmaceuticals, from 2001 to 2002, and as Senior Executive Vice President and Chief Financial Officer and as a director of Bergen Brunswig Corporation, a wholesale distributor of pharmaceuticals, for more than five years prior to its merger in 2001 with AmeriSource Health Corporation to form AmerisourceBergen. He also serves as a member of the boards of directors of the following companies: Alliance Imaging Inc., a provider of outsourced diagnostic imaging services to hospitals and other healthcare companies; Global Resources Professionals, an international professional services firm that provides outsourced services to companies on a project basis; Mylan Laboratories, Inc., a pharmaceutical manufacturer; and Thoratec Corporation, a developer of products to treat cardiovascular disease. Mr. Dimick’s qualifications for membership on WebMD’s Board of Directors include: his prior service as a director of WebMD and HLTH; his experience as a director of other public companies, as described above; his experience as a public company chief financial officer, as described above; and his experience, prior to that, as a CPA and partner of a public accounting firm. |
Jerome Keller |
Mr. Jerome C. Keller is Independent Director of WebMD Health Corporation since September 2005. From 1997 until he retired in October 2005, Mr. Keller served as Senior Vice President, Sales and Marketing at Martek Biosciences Corporation, a company that develops and sells microalgae products, and he served from October 2005 until its acquisition by Royal DSM N.V. in February 2011, as a member of its board of directors. He served as Vice President of Sales for Merck & Co. Inc., a pharmaceutical company, from 1986 to 1993. Mr. Keller’s qualifications for membership on WebMD’s Board of Directors include: his prior service as a member of the WebMD Board; his service on the Board of Directors of Martek; and his many years of experience as an executive of and consultant to pharmaceutical manufacturers and other healthcare companies. |
James Manning |
Mr. James V. Manning is Independent Director of WebMD Health Corporation since September 2005. From September 2000 until completion of the Merger in October 2009, Mr. Manning was a member of HLTH’s Board of Directors. Prior to that, he was a member of a predecessor company’s board of directors for more than five years. Mr. Manning’s qualifications for membership on WebMD’s Board of Directors include: his prior service as a director of WebMD, HLTH and predecessor companies in the healthcare industry; his experience as a chief financial officer of several public companies (including of Medco Containment Services, Inc. for more than five years prior to 1994); and his experience, prior to that, as a CPA and partner of a public accounting firm. |
Abdool Moossa |
Dr. Abdool Rahim Moossa, M.D., is Independent Director of WebMD Health Corporation since September 2005. Since 2003, he has served as the Distinguished Professor of Surgery and Emeritus Chairman of the Department of Surgery, at the School of Medicine, University of California, San Diego (UCSD). From 2003 to 2009, Dr. Moossa also served as Associate Dean and Special Counsel to the Vice Chancellor for Health Sciences and Director of Tertiary and Quaternary Referral Services for UCSD. Prior to that, he served as Professor and Chairman, Department of Surgery, UCSD from 1983 to 2003. He also serves as a member of the board of directors of the Foundation for Surgical Education. Dr. Moossa’s qualifications for membership on WebMD’s Board of Directors include: his prior service on the WebMD Board; and his many years of experience as a physician and as an educator of physicians. |
Herman Sarkowsky |
Mr. Herman Sarkowsky is Independent Director of WebMD Health Corporation October 2009, upon completion of the Merger. Mr. Sarkowsky was a member of HLTH’s Board of Directors from November 2000 until the Merger. Prior to that, he was a member of a predecessor company’s board of directors for more than five years. Mr. Sarkowsky has been President of Sarkowsky Investment Corporation, a private investment company, for more than five years. From July 2010 until December 2011, Mr. Sarkowsky was a member of the Board of Directors of Power Efficiency Corp., which develops and markets energy saving technologies for electric motors. Since 2009, Mr. Sarkowsky has been a member of The UW Medicine Board, which advises and assists the chief executive officer and the dean of the School of Medicine of the University of Washington in strategic planning and oversight of programs across UW Medicine. Prior to that, Mr. Sarkowsky served on the University of Washington Hospital Board for 12 years, during two of which he was chairman of that board. |
Joseph Smith |
Mr. Joseph E. Smith is Independent Director of WebMD Health Corporation since October 2009, upon completion of the Merger. Mr. Smith was a member of HLTH’s Board of Directors from September 2000 until the Merger. Mr. Smith served in various positions with Warner-Lambert Company, a pharmaceutical company, from March 1989 to September 1997, the last of which was Corporate Executive Vice President and a member of the Office of the Chairman and the firm’s Management Committee. Mr. Smith is a member of the Board of Directors of Par Pharmaceutical Companies, Inc., a manufacturer and distributor of generic and branded pharmaceuticals, and serves as Lead Director of that board. He is a member of the Board of Trustees of the International Longevity Center, a non-profit organization. |
Stanley Trotman |
Mr. Stanley S. Trotman, Jr., is Independent Director of WebMD Health Corporation since September 2005. Mr. Trotman retired in 2001 from UBS Financial Services, Inc. after it acquired, in 2000, PaineWebber Incorporated, an investment banking firm where he had been a Managing Director with the Health Care Group since 1995. He serves as a member of the board of directors of American Shared Hospital Services, a public company that provides radio surgery services to medical centers for use in brain surgery. He also serves as a director of Ascend Health Care Corp., a privately-held company that provides services to acute psychiatric patients. Mr. Trotman’s qualifications for membership on WebMD’s Board of Directors include: his prior service as a director of WebMD; his experience as a director of other public and private companies in various aspects of the healthcare industry; and his experience as an investment banker specializing in healthcare companies. |
Risa Fisher |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Martin Wygod |
9,642,410 |
David Schlanger |
-- |
Peter Anevski |
-- |
William Pence |
1,872,550 |
Douglas Wamsley |
-- |
David Marek |
-- |
Steven Zatz |
2,131,840 |
Kevin Cameron |
-- |
Thomas Coleman |
-- |
David Schechter |
-- |
Mark Adler |
-- |
Neil Dimick |
-- |
Jerome Keller |
-- |
James Manning |
-- |
Abdool Moossa |
-- |
Herman Sarkowsky |
-- |
Joseph Smith |
-- |
Stanley Trotman |
-- |
Risa Fisher |
-- |
As Of 30 Dec 2011
Options Compensation
| Name | Options | Value |
|---|---|---|
Martin Wygod |
3,927,220 | 2,967,957 |
David Schlanger |
0 | 0 |
Peter Anevski |
0 | 0 |
William Pence |
37,500 | 966,723 |
Douglas Wamsley |
0 | 0 |
David Marek |
0 | 0 |
Steven Zatz |
128,135 | 1,365,780 |
Kevin Cameron |
0 | 0 |
Thomas Coleman |
0 | 0 |
David Schechter |
0 | 0 |
Mark Adler |
0 | 0 |
Neil Dimick |
0 | 0 |
Jerome Keller |
0 | 0 |
James Manning |
0 | 0 |
Abdool Moossa |
0 | 0 |
Herman Sarkowsky |
0 | 0 |
Joseph Smith |
0 | 0 |
Stanley Trotman |
0 | 0 |
Risa Fisher |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
SCHLANGER DAVID J |
456 | $29.60 |
ANEVSKI PETER |
925 | $29.60 |
GLICK MICHAEL B |
820 | $29.53 |
ANEVSKI PETER |
20,000 | $0.00 |
SCHLANGER DAVID J |
30,000 | $0.00 |
SCHLANGER DAVID J |
30,000 | $0.00 |
WYGOD MARTIN J |
75,000 | $0.00 |
WYGOD MARTIN J |
5,637 | $24.32 |
VUOLO ANTHONY |
4,529 | $24.32 |
WAMSLEY DOUGLAS W |
1,866 | $24.32 |
PENCE WILLIAM EDWARD IV |
1,140 | $24.32 |
ZATZ STEVEN L |
2,202 | $24.32 |
GLICK MICHAEL B |
349 | $24.70 |
ZATZ STEVEN L |
20,000 | $0.00 |
PENCE WILLIAM EDWARD IV |
20,000 | $0.00 |
GLICK MICHAEL B |
10,000 | $0.00 |
WAMSLEY DOUGLAS W |
10,000 | $0.00 |
GLICK MICHAEL B |
1,105 | $13.79 |
VUOLO ANTHONY |
5,068 | $13.48 |
MOOSSA ABDOOL RAHIM |
2,640 | $14.20 |
SARKOWSKY HERMAN |
2,640 | $14.20 |
SCHECHTER DAVID S |
2,112 | $14.20 |
DIMICK NEIL F |
3,873 | $14.20 |
KELLER JEROME C |
2,640 | $14.20 |
ADLER MARK J |
2,816 | $14.20 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
